Phase 2 COVID Clinical Trials
68 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 68 trials
Recruiting
Phase 2
Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
Long COVID
ParagonClinicals Inc.82 enrolled4 locationsNCT07627815
Recruiting
Phase 1Phase 2
AGILE (Early Phase Platform Trial for COVID-19)
COVID19
University of Liverpool600 enrolled7 locationsNCT04746183
Recruiting
Phase 2Phase 3
Taurine Supplementation in Long COVID
Long COVID
University of Alberta300 enrolled5 locationsNCT06721949
Recruiting
Phase 2
Defibrotide for the Treatment of Severe COVID-19
COVID19
Brigham and Women's Hospital42 enrolled1 locationNCT04652115
Recruiting
Phase 2
A Nasal Treatment for COVID-19
HealthyCOVID-19
Indiana University40 enrolled1 locationNCT05799521
Recruiting
Phase 2
A Study to Assess Anktiva in Patients With Long Covid-19.
Long COVID
ImmunityBio, Inc.20 enrolled1 locationNCT07108036
Recruiting
Phase 2
A Study to Examine Anktiva for the Treatment of COVID-19.
Long COVIDLong COVID SyndromeLong Covid 19
ImmunityBio, Inc.40 enrolled1 locationNCT07123727
Recruiting
Phase 2
Imaging Immune Activation in COVID-19
COVID19SARS-CoV Infection
CellSight Technologies, Inc.80 enrolled1 locationNCT04815096
Recruiting
Phase 2
Arginine Replacement Therapy in COVID-19
COVID-19
Emory University21 enrolled1 locationNCT05855330
Recruiting
Phase 1Phase 2
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
COVID19
New York Medical College50 enrolled4 locationsNCT04896606
Recruiting
Phase 1Phase 2
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting
Phase 2
Sonlicromanol in Post-COVID
Post-COVID Condition
Michele van Vugt80 enrolled1 locationNCT07298005
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)
Post COVID-19 ConditionLong COVIDLong COVID Syndrome+2 more
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia90 enrolled1 locationNCT06766825
Recruiting
Phase 2Phase 3
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Long COVIDSmell DysfunctionOlfactory Disorder
Medical University of South Carolina145 enrolled1 locationNCT05855369
Recruiting
Phase 2
DAOIB for the Treatment of Brain Fog
Long COVID
Chang Gung Memorial Hospital40 enrolled1 locationNCT05764538
Recruiting
Phase 2
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
COVID-19SARS-CoV Infection
University of Texas Southwestern Medical Center112 enrolled1 locationNCT05886816
Recruiting
Phase 1Phase 2
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic EncephalomyelitisChronic Fatigue SyndromePost-treatment Lyme Disease Syndrome+1 more
Icahn School of Medicine at Mount Sinai120 enrolled1 locationNCT06511050
Recruiting
Phase 2
Antiviral Clinical Trial for Long Covid-19
Long COVID
Icahn School of Medicine at Mount Sinai90 enrolled1 locationNCT06511063
Recruiting
Phase 2
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting
Phase 2
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center80 enrolled1 locationNCT05672355